Table of Contents
Advances in Biology
Volume 2015, Article ID 527231, 10 pages
http://dx.doi.org/10.1155/2015/527231
Research Article

Sodium Butyrate Plus EGF and PDGF-BB Aids Cutaneous Wound Healing in Diabetic Mice

1Department of Human Genetics, NIMHANS, Bangalore 560029, India
2Department of Studies in Sericulture/Life Sciences, Bangalore University, Bangalore 560056, India

Received 10 August 2015; Revised 13 October 2015; Accepted 13 October 2015

Academic Editor: Paul J. Higgins

Copyright © 2015 Rohini Keshava and Rajalakshmi Gope. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. J. Jeffcoate and K. G. Harding, “Diabetic foot ulcers,” The Lancet, vol. 361, no. 9368, pp. 1545–1551, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A. J. Boulton, L. Vileikyte, G. Ragnarson-Tennvall, and J. Apelqvist, “The global burden of diabetic foot disease,” The Lancet, vol. 366, no. 9498, pp. 1719–1724, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Gope, “The effect of epidermal growth factor & platelet-derived growth factors on wound healing process,” Indian Journal of Medical Research, vol. 116, no. 4, pp. 201–206, 2002. View at Google Scholar · View at Scopus
  4. M. L. Gope and R. Gope, “Topically applied EGF and PDGFs affect positively the co-ordinate expression of EGF and PDGF receptor genes during acute cutaneous wound-healing process,” Current Science, vol. 92, no. 5, pp. 618–627, 2007. View at Google Scholar · View at Scopus
  5. M. L. Gope and R. Gope, “Tyrosine phosphorylation of EGF-R and PDGF-R proteins during acute cutaneous wound healing process in mice,” Wound Repair and Regeneration, vol. 17, no. 1, pp. 71–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. W. Tsang, W. K. R. Wong, C. S. Hung et al., “Human epidermal growth factor enhances healing of diabetic foot ulcers,” Diabetes Care, vol. 26, no. 6, pp. 1856–1861, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Dogan, S. Demirer, I. Kepenekci et al., “Epidermal growth factor-containing wound closure enhances wound healing in non-diabetic and diabetic rats,” International Wound Journal, vol. 6, no. 2, pp. 107–115, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. R. L. Brown, M. P. Breeden, and D. G. Greenhalgh, “PDGF and TGF-α act synergistically to improve wound healing in the genetically diabetic mouse,” Journal of Surgical Research, vol. 56, no. 6, pp. 562–570, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. D. G. Greenhalgh, K. H. Sprugel, M. J. Murray, and R. Ross, “PDGF and FGF stimulate wound healing in the genetically diabetic mouse,” The American Journal of Pathology, vol. 136, no. 6, pp. 1235–1246, 1990. View at Google Scholar · View at Scopus
  10. G. R. Grotendorst, G. R. Martin, D. Pencev, J. Sodek, and A. K. Harvey, “Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats,” The Journal of Clinical Investigation, vol. 76, no. 6, pp. 2323–2329, 1985. View at Publisher · View at Google Scholar · View at Scopus
  11. A. A. Like and A. A. Rossini, “Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus,” Science, vol. 193, no. 4251, pp. 415–417, 1976. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Song, B. Xia, and J. Li, “Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1β, and nuclear factor κB in trinitrobenzene sulphonic acid induced colitis in rats,” Postgraduate Medical Journal, vol. 82, no. 964, pp. 130–135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Gope and M. L. Gope, “Effect of sodium butyrate on the expression of retinoblastoma (RB1) and P53 gene and phosphorylation of retinoblastoma protein in human colon tumor cell line HT29.,” Cellular and Molecular Biology, vol. 39, no. 6, pp. 589–597, 1993. View at Google Scholar · View at Scopus
  14. T. Davis, C. Kennedy, Y.-E. Chiew, C. L. Clarke, and A. Defazio, “Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells,” Clinical Cancer Research, vol. 6, no. 11, pp. 4334–4342, 2000. View at Google Scholar · View at Scopus
  15. Y. Karasawa and S. Okisaka, “Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells,” Japanese Journal of Ophthalmology, vol. 48, no. 6, pp. 542–551, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Barham and P. Trinder, “An improved color reagent for the determination of blood glucose by the oxidase system,” Analyst, vol. 97, no. 1151, pp. 142–145, 1972. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Mitra, B. Indira Devi, M. L. Gope, D. K. Subbakrishna, and R. Gope, “Sodium butyrate modulates pRb phosphorylation and induces cell death in human vestibular schwannomas in vitro,” Indian Journal of Experimental Biology, vol. 50, no. 1, pp. 19–27, 2012. View at Google Scholar · View at Scopus
  18. P. Martin, “Wound healing—aiming for perfect skin regeneration,” Science, vol. 276, no. 5309, pp. 75–81, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. A. J. Singer and R. A. F. Clark, “Cutaneous wound healing,” The New England Journal of Medicine, vol. 341, no. 10, pp. 738–746, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. R. S. Most and P. Sinnock, “The epidemiology of lower extremity amputations in diabetic individuals,” Diabetes Care, vol. 6, no. 1, pp. 87–91, 1983. View at Publisher · View at Google Scholar · View at Scopus
  21. G. E. Reiber, B. A. Lipsky, and G. W. Gibbons, “The burden of diabetic foot ulcers,” The American Journal of Surgery, vol. 176, no. 2, supplement 2, pp. 5S–10S, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. D. M. Cooper, E. Z. Yu, P. Hennessey et al., “Determination of endogenous cytokines in chronic wounds,” Annals of Surgery, vol. 219, no. 6, pp. 688–692, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. N. T. Bennett and G. S. Schultz, “Growth factors and wound healing. Part II. Role in normal and chronic wound healing,” The American Journal of Surgery, vol. 166, no. 1, pp. 74–81, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. E. K. LeGrand, T. C. Kiorpes, J. F. Burke, and D. E. Costa, “Dose responsive effects of PDGF-BB, PDGF-AA, EGF, and bFGF on granulation tissue in a Guinea pig partial thickness skin excision model,” Growth Factors, vol. 8, no. 4, pp. 307–314, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. G. L. Brown, L. B. Nanney, J. Griffen et al., “Enhancement of wound healing by topical treatment with epidermal growth factor,” The New England Journal of Medicine, vol. 321, no. 2, pp. 76–79, 1989. View at Publisher · View at Google Scholar · View at Scopus
  26. C.-H. Heldin and B. Westermark, “Mechanism of action and in vivo role of platelet-derived growth factor,” Physiological Reviews, vol. 79, no. 4, pp. 1283–1316, 1999. View at Google Scholar · View at Scopus
  27. R. L. Brown, M. P. Breeden, and D. G. Greenhalgh, “PDGF and TGF-α act synergistically to improve wound healing in the genetically diabetic mouse,” Journal of Surgical Research, vol. 56, no. 6, pp. 562–570, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Leon Carrion, C. H. Sutter, and T. R. Sutter, “Combined treatment with sodium butyrate and PD153035 enhances keratinocyte differentiation,” Experimental Dermatology, vol. 23, no. 3, pp. 211–214, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Lagger, D. O'Carroll, M. Rembold et al., “Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression,” The EMBO Journal, vol. 21, no. 11, pp. 2672–2681, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Jamaladdin, R. D. W. Kelly, L. O'Regan et al., “Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 27, pp. 9840–9845, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. M. D. Planas-Silva and R. A. Weinberg, “The restriction point and control of cell proliferation,” Current Opinion in Cell Biology, vol. 9, no. 6, pp. 768–772, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. S. A. Eming, M. Koch, A. Krieger et al., “Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds,” Journal of Proteome Research, vol. 9, no. 9, pp. 4758–4766, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. G. P. Fadini, M. Albiero, R. Millioni et al., “The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker,” Diabetologia, vol. 57, no. 9, pp. 1947–1956, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Hamed, C. L. Bennett, C. Demiot, Y. Ullmann, L. Teot, and A. Desmoulière, “Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus,” Wound Repair and Regeneration, vol. 22, no. 1, pp. 23–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Kruh, “Effects of sodium butyrate, a new pharmacological agent, on cells in culture,” Molecular and Cellular Biochemistry, vol. 42, no. 2, pp. 65–82, 1981. View at Google Scholar · View at Scopus
  36. R. Mitra, R. Keshava, J. Mathivanan, V. Vikas, B. Indira Devi, and R. Gope, “Bay 61-3606, CDKi, and sodium butyrate treatments modulate p53 protein level and its site-specific phosphorylation in human vestibular schwannomas in vitro,” Journal of Cancer Research, vol. 2014, Article ID 249354, 9 pages, 2014. View at Publisher · View at Google Scholar
  37. N. Burger-van Paassen, A. Vincent, P. J. Puiman et al., “The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: Implications for epithelial protection,” Biochemical Journal, vol. 420, no. 2, pp. 211–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. Food and Drug Administration, FDA Talk Paper, U.S. Department of Health and Human Services, Rockville, Md, USA, 1997.